[MO35] Mini-Oral Session 35　Palliative Care / Symptom Management 1
【E】

[MO35-6] Surveillance of use and compliance for Japanese Guidelines on Febrile Neutropenia in oncology physicians: 2nd report

^○Nobu Akiyama¹, Takuho Okamura², Minoru Yoshida³, Shun-Ichi Kimura⁴, Shingo Yano⁵, Isao Yoshida⁶, Hitoshi Kusaba⁷, Kosuke Takahashi⁸, Hiroyuki Fujita⁹, Keitaro Fukushima¹⁰, Hiromichi Iwasaki¹¹, Kazuo Tamura¹², Toshiaki Saeki¹³, Yasushi Takamatsu¹⁴, Sadamoto Zenda¹⁵ (1.Center for Blood Tranfusion and Cell-therapy, Teikyo University, 2.Department of Breast Surgery, School of Medicine, Tokai University, 3.Fourth Department of Internal Medicine, Teikyo University Hospital Mizonokuchi, 4.Division of Hematology, Jichi Medical University Saitama Medical Center, 5.Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 6.National Hospital Organization Shikoku Cancer Center, Department of Hematologic Oncology, 7.Department of Comprehensive Clinical Oncology, Faculty of Medical Sciences, 8.Department of Respiratory Medicine, Anjo Kosei Hospital, 9.Department of Hematology, Saiseikai Yokohama Nanbu Hospital, 10.Department of Pediatrics, Dokkyo Medical University, 11.Department of Infection Control and Prevention, Faculty of Medical Sciences, University of Fukui, 12.Professor Emeritus, Fukuoka University, 13.Department of Breast Oncology, Saitama Medical University International Medical Center, 14.Department of Hematology, Oncology, Endocrinology and Infectious disease, Fukuoka University, Fukuoka, 15.National Cancer Center Hospital East, Department of Radiation Oncology)